← back to “Diagnosis and Treatment of Graves’ Disease”
fig8
Figure 8. In this patient with Graves’ Disease, the mixture of antibodies shifted during antithyroid therapy from dominance by TSAb, to a dominant effect by TSBAb and TBII, leading to spontaneous development of hypothyroidism. From Takasu et al, J. Endocrinol. Invest. 20:452-461, 1997.